About one-third of all drugs approved by the Food and Drug Administration target the largest family of cell membrane ...
About one-third of all drugs approved by the Food and Drug Administration target the largest family of cell membrane receptors called G ...
News-Medical.Net on MSN
Researchers uncover and inhibit a key cell death pathway in severe cutaneous adverse reactions
Dr. Akito Hasegawa (Assistant Professor), and Prof. Riichiro Abe from the Division of Dermatology, Niigata University ...
Niigata, Japan - A collaborative research group led by Haruna Kimura (graduate student), Dr. Akito Hasegawa (Assistant Professor), and Prof. Riichiro ...
The authors describe an interesting approach to studying the dynamics and function of membrane proteins in different lipid environments. The important findings have theoretical and practical ...
Pharmaceutical Technology on MSN
Nabla Bio expands Takeda collab for protein therapeutics
Nabla Bio has entered a new multi-year research collaboration with Takeda to advance AI-driven design of protein therapeutics ...
SAN DIEGO, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced three abstracts from its clinical development programs will be presented at the upcoming ...
Confo Therapeutics NV has secured a 2-year €1 million (US$1.2 million) grant from Flanders Innovation & Entrepreneurship ...
Nabla Bio signs research collaboration with Takeda to advance AI-driven design of protein therapeutics: Cambridge, Massachusetts Wednesday, October 15, 2025, 15:00 Hrs [IST] Nabla ...
Nabla to receive upfront and research cost payments in double-digit millions and eligible to receive success-based payments that may exceed $1 billionMulti-year partnership deploys Nabla Bio’s AI ...
A research team has outlined how synthetic biology can accelerate discoveries in plant–microbe interactions, offering ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback